Maternal serum dehydroepiandrosterone sulfate levels and successful labor induction

J. Goolsby, J. Mariulla, C. Racowsky, Kathryn L Reed

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To evaluate the maternal serum dehydroepiandrosterone (DHEA) sulfate level as a factor affecting the outcome of labor induction. STUDY DESIGN: After obtaining consent, venous blood was collected at the initiation of labor induction from 139 women. Pregnancies complicated by chronic maternal corticosteroid use, antepartum chorioamnionitis, or intrapartum fetal distress resulting in cesarean delivery were excluded from analysis. In those 133 women meeting inclusion criteria, induction methods included intravenous oxytocin and/or intravaginal prostaglandin gel following established protocols. Serum DHEA sulfate levels were measured by radioimmunoassay. DHEA sulfate levels were correlated with the success or failure of each attempt. A success was defined as progression to vaginal delivery prior to discharge from the labor and delivery unit. Linear correlation, the Welch approximate t-test, and Fisher's exact test were utilized for statistical analysis, with P < 0.05 considered statistically significant. RESULTS: Serum DHEA sulfate levels correlated significantly with the length of time from initiation of induction to deliver)- (r = -0.19, P = 0.03). The mean (± standard error) DHEA sulfate level approached significance in women who progressed successfully to vaginal delivery compared to those with unsuccessful attempts (112.27 ±6.37 vs 87.53 ± 10.67 (JLg/dl, respectively; P = 0.06). As compared with women having DHEA sulfate levels >70 μg/dl, women with levels ≤70 μg/dl had a relative risk = 2.05 (95% confidence interval of 0.92-4.54) for unsuccessful induction (P = 0.11). CONCLUSION: Higher maternal serum DHEA sulfate levels correlate significantly with a shorter length of labor. Among women undergoing induction of labor, maternal serum DHEA sulfate levels are higher in those who progress successfully to vaginal delivery than in those with unsuccessful attempts; however, this difference does not reach statistical significance with the current sample si/e. DHEA sulfate may be an important factor in successful labor induction.

Original languageEnglish (US)
JournalActa Diabetologica Latina
Volume176
Issue number1 PART II
StatePublished - 1997

Fingerprint

Induced Labor
Dehydroepiandrosterone Sulfate
Mothers
Serum
Chorioamnionitis
Fetal Distress
Oxytocin
Prostaglandins
Radioimmunoassay
Adrenal Cortex Hormones
Gels
Confidence Intervals
Pregnancy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Maternal serum dehydroepiandrosterone sulfate levels and successful labor induction. / Goolsby, J.; Mariulla, J.; Racowsky, C.; Reed, Kathryn L.

In: Acta Diabetologica Latina, Vol. 176, No. 1 PART II, 1997.

Research output: Contribution to journalArticle

Goolsby, J. ; Mariulla, J. ; Racowsky, C. ; Reed, Kathryn L. / Maternal serum dehydroepiandrosterone sulfate levels and successful labor induction. In: Acta Diabetologica Latina. 1997 ; Vol. 176, No. 1 PART II.
@article{d0e0063443c443ddab358ee0a78c4019,
title = "Maternal serum dehydroepiandrosterone sulfate levels and successful labor induction",
abstract = "OBJECTIVE: To evaluate the maternal serum dehydroepiandrosterone (DHEA) sulfate level as a factor affecting the outcome of labor induction. STUDY DESIGN: After obtaining consent, venous blood was collected at the initiation of labor induction from 139 women. Pregnancies complicated by chronic maternal corticosteroid use, antepartum chorioamnionitis, or intrapartum fetal distress resulting in cesarean delivery were excluded from analysis. In those 133 women meeting inclusion criteria, induction methods included intravenous oxytocin and/or intravaginal prostaglandin gel following established protocols. Serum DHEA sulfate levels were measured by radioimmunoassay. DHEA sulfate levels were correlated with the success or failure of each attempt. A success was defined as progression to vaginal delivery prior to discharge from the labor and delivery unit. Linear correlation, the Welch approximate t-test, and Fisher's exact test were utilized for statistical analysis, with P < 0.05 considered statistically significant. RESULTS: Serum DHEA sulfate levels correlated significantly with the length of time from initiation of induction to deliver)- (r = -0.19, P = 0.03). The mean (± standard error) DHEA sulfate level approached significance in women who progressed successfully to vaginal delivery compared to those with unsuccessful attempts (112.27 ±6.37 vs 87.53 ± 10.67 (JLg/dl, respectively; P = 0.06). As compared with women having DHEA sulfate levels >70 μg/dl, women with levels ≤70 μg/dl had a relative risk = 2.05 (95{\%} confidence interval of 0.92-4.54) for unsuccessful induction (P = 0.11). CONCLUSION: Higher maternal serum DHEA sulfate levels correlate significantly with a shorter length of labor. Among women undergoing induction of labor, maternal serum DHEA sulfate levels are higher in those who progress successfully to vaginal delivery than in those with unsuccessful attempts; however, this difference does not reach statistical significance with the current sample si/e. DHEA sulfate may be an important factor in successful labor induction.",
author = "J. Goolsby and J. Mariulla and C. Racowsky and Reed, {Kathryn L}",
year = "1997",
language = "English (US)",
volume = "176",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia",
number = "1 PART II",

}

TY - JOUR

T1 - Maternal serum dehydroepiandrosterone sulfate levels and successful labor induction

AU - Goolsby, J.

AU - Mariulla, J.

AU - Racowsky, C.

AU - Reed, Kathryn L

PY - 1997

Y1 - 1997

N2 - OBJECTIVE: To evaluate the maternal serum dehydroepiandrosterone (DHEA) sulfate level as a factor affecting the outcome of labor induction. STUDY DESIGN: After obtaining consent, venous blood was collected at the initiation of labor induction from 139 women. Pregnancies complicated by chronic maternal corticosteroid use, antepartum chorioamnionitis, or intrapartum fetal distress resulting in cesarean delivery were excluded from analysis. In those 133 women meeting inclusion criteria, induction methods included intravenous oxytocin and/or intravaginal prostaglandin gel following established protocols. Serum DHEA sulfate levels were measured by radioimmunoassay. DHEA sulfate levels were correlated with the success or failure of each attempt. A success was defined as progression to vaginal delivery prior to discharge from the labor and delivery unit. Linear correlation, the Welch approximate t-test, and Fisher's exact test were utilized for statistical analysis, with P < 0.05 considered statistically significant. RESULTS: Serum DHEA sulfate levels correlated significantly with the length of time from initiation of induction to deliver)- (r = -0.19, P = 0.03). The mean (± standard error) DHEA sulfate level approached significance in women who progressed successfully to vaginal delivery compared to those with unsuccessful attempts (112.27 ±6.37 vs 87.53 ± 10.67 (JLg/dl, respectively; P = 0.06). As compared with women having DHEA sulfate levels >70 μg/dl, women with levels ≤70 μg/dl had a relative risk = 2.05 (95% confidence interval of 0.92-4.54) for unsuccessful induction (P = 0.11). CONCLUSION: Higher maternal serum DHEA sulfate levels correlate significantly with a shorter length of labor. Among women undergoing induction of labor, maternal serum DHEA sulfate levels are higher in those who progress successfully to vaginal delivery than in those with unsuccessful attempts; however, this difference does not reach statistical significance with the current sample si/e. DHEA sulfate may be an important factor in successful labor induction.

AB - OBJECTIVE: To evaluate the maternal serum dehydroepiandrosterone (DHEA) sulfate level as a factor affecting the outcome of labor induction. STUDY DESIGN: After obtaining consent, venous blood was collected at the initiation of labor induction from 139 women. Pregnancies complicated by chronic maternal corticosteroid use, antepartum chorioamnionitis, or intrapartum fetal distress resulting in cesarean delivery were excluded from analysis. In those 133 women meeting inclusion criteria, induction methods included intravenous oxytocin and/or intravaginal prostaglandin gel following established protocols. Serum DHEA sulfate levels were measured by radioimmunoassay. DHEA sulfate levels were correlated with the success or failure of each attempt. A success was defined as progression to vaginal delivery prior to discharge from the labor and delivery unit. Linear correlation, the Welch approximate t-test, and Fisher's exact test were utilized for statistical analysis, with P < 0.05 considered statistically significant. RESULTS: Serum DHEA sulfate levels correlated significantly with the length of time from initiation of induction to deliver)- (r = -0.19, P = 0.03). The mean (± standard error) DHEA sulfate level approached significance in women who progressed successfully to vaginal delivery compared to those with unsuccessful attempts (112.27 ±6.37 vs 87.53 ± 10.67 (JLg/dl, respectively; P = 0.06). As compared with women having DHEA sulfate levels >70 μg/dl, women with levels ≤70 μg/dl had a relative risk = 2.05 (95% confidence interval of 0.92-4.54) for unsuccessful induction (P = 0.11). CONCLUSION: Higher maternal serum DHEA sulfate levels correlate significantly with a shorter length of labor. Among women undergoing induction of labor, maternal serum DHEA sulfate levels are higher in those who progress successfully to vaginal delivery than in those with unsuccessful attempts; however, this difference does not reach statistical significance with the current sample si/e. DHEA sulfate may be an important factor in successful labor induction.

UR - http://www.scopus.com/inward/record.url?scp=33748631015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748631015&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33748631015

VL - 176

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 1 PART II

ER -